MetLife 과거 순이익 실적
과거 기준 점검 1/6
MetLife의 수입은 연평균 -8%의 비율로 감소해 온 반면, Insurance 산업은 수입이 연평균 14.6% 증가했습니다. 매출은 연평균 1.9%의 비율로 증가해 왔습니다. MetLife의 자기자본이익률은 13%이고 순이익률은 4.4%입니다.
핵심 정보
-8.02%
순이익 성장률
-1.48%
주당순이익(EPS) 성장률
| Insurance 산업 성장률 | 8.02% |
| 매출 성장률 | 1.87% |
| 자기자본이익률 | 13.00% |
| 순이익률 | 4.43% |
| 최근 순이익 업데이트 | 31 Mar 2026 |
최근 과거 실적 업데이트
Recent updates
내러티브 업데이트 • May 03
MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential
Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.Seeking Alpha • Apr 26
MetLife: A Great Time To Buy The Preferred Stock
Summary MetLife preferred shares now yield over 6% as rising rates pressure prices, offering attractive risk/reward for long-term investors. MET's preferred dividends are well covered, with payout ratios under 4% of adjusted earnings and likely dropping to 3% as EPS grows. Series F preferred, MET.PR.F, trades at ~$19.25 for a 6.15% yield. Low payout ratio and strong balance sheet support continued payments. Double-digit adjusted EPS growth and 15–17% ROE guidance suggest MET common shares also offer compelling upside below $80/share. Read the full article on Seeking Alpha내러티브 업데이트 • Apr 17
MET: Share Repurchases Following Index Exit Will Support Future Upside Potential
Analysts have slightly reduced their MetLife fair value estimate to $89.06 from $90.50, reflecting minor adjustments to assumptions for the discount rate, revenue growth, profit margin, and future P/E ratio that refine their outlook for the shares. What's in the News MetLife has been dropped from the S&P 100 index, which may influence how some index funds and benchmarks gain exposure to the stock (Key Developments).내러티브 업데이트 • Apr 01
MET: Share Repurchases And Index Exit Will Shape Future Upside Potential
Analysts have trimmed their average MetLife price target slightly to $90.50 from $90.73, citing updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News MetLife, Inc.내러티브 업데이트 • Mar 18
MET: Share Repurchases Will Support Future Upside Potential
Analysts have slightly adjusted their price target for MetLife to $90.73 from $90.93, reflecting updated views on discount rates, revenue growth, profit margins, and future price-to-earnings (P/E) assumptions. What's in the News MetLife reported that from October 1, 2025 to January 31, 2026 it repurchased 7,608,263 shares, representing 1.15% of shares, for a total of US$600 million under its current buyback program (Key Developments).내러티브 업데이트 • Mar 04
MET: Buybacks And Retirement Income Agreements Will Drive Future Upside
Analysts have trimmed their price target on MetLife to about $90.93 from roughly $92.93. This reflects updated views on slightly lower expected revenue growth, a modestly softer profit margin, a higher discount rate, and a largely unchanged future P/E assumption.내러티브 업데이트 • Dec 16
MET: Retirement Income Agreements Will Drive Future Upside In Earnings Power
Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.내러티브 업데이트 • Nov 07
MET: Revenue Will Advance On New Retirement Income And Employee Support Agreements
Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.내러티브 업데이트 • Oct 24
Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead
Analysts have modestly raised their price target for MetLife, increasing it from $93.00 to $93.33 per share. They cited slight improvements in projected revenue growth and profit margins as the reason for the adjustment.내러티브 업데이트 • Oct 09
International Demand And Digital Transformation Will Fuel Success
Analysts have raised their fair value estimate for MetLife from $91.86 to $93.00. This reflects slight adjustments to discount rates and growth assumptions.내러티브 업데이트 • Sep 04
International Demand And Digital Transformation Will Fuel Success
With no change in revenue growth forecasts or discount rate, MetLife’s fair value estimate remains steady at $91.86. What's in the News MetLife will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, at $1,000 per share; dividends of $19.250 per share will be paid separately, and all further dividends cease post-redemption.분석 기사 • Jun 11
It's Unlikely That MetLife, Inc.'s (NYSE:MET) CEO Will See A Huge Pay Rise This Year
Key Insights MetLife's Annual General Meeting to take place on 17th of June Salary of US$1.50m is part of CEO Michel...Seeking Alpha • Feb 11
MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart
Summary MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite recent earnings misses. Insurance stocks, including MET, have lagged behind the Financials sector and S&P 500, with premium increases expected to slow as consumers react to rising costs. MET's 2025 outlook is positive, with analysts forecasting over 17% EPS growth and 5%-6% revenue growth, despite recent underperformance in certain segments. Key risks include lower stock prices, falling interest rates, and regulatory challenges, but MET's strong investment income and share buybacks are positive factors. Read the full article on Seeking AlphaSeeking Alpha • Nov 26
MetLife Upgraded To Buy As Financials And Insurance Show Further Upside Potential
Summary MetLife stock gets upgraded to a buy, from my prior hold rating, as indicators point to further share price potential in the financials sector, as well as the insurance subsector. Data points to future continued demand for annuities and life insurance, and MetLife has in Q3 achieved new organic customer growth in 2 key businesses. Although its dividend yield is not stellar vs. peers, it has a 10-year track record of proven dividend growth, something it has potential to continue. Even though it is trading at a 10-year high, it remains undervalued on P/E and EV/EBITDA vs. peers, so continues to present a buy opportunity. Read the full article on Seeking AlphaSeeking Alpha • Sep 23
MetLife: One Of The Best Life Insurance Stocks
Summary MetLife's strong financial performance, with a 17.5% increase in adjusted EPS and a 15.2% rise in book value, makes it an attractive investment. Despite comparable performance to Aflac, MetLife's lower valuation offers better value for shareholders. MetLife's growing dividend yield and robust share buyback program enhance shareholder value, with ample cash reserves supporting future buybacks. Risks include potential commercial real estate portfolio defaults and market volatility, but MetLife's strong fundamentals and attractive valuation make it a compelling choice. Read the full article on Seeking AlphaSeeking Alpha • Jul 09
Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield
Summary MetLife's preferred shares, particularly the Series A with floating dividends, offer potential for investors in a 'higher for longer' inflation and interest rate environment. MetLife's strong financial performance in Q1 2021, with net profit covering preferred dividends by less than 8%. Series A preferred shares have a minimum 4% floor for dividends, with potential for higher yields based on 3 month SOFR rate adjustments. Read the full article on Seeking AlphaSeeking Alpha • Jun 26
MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood
Summary MetLife shares have outperformed peers, but life insurance stocks have not really been in favor given concerns about CRE losses and rate cuts. Higher rates have allowed MetLife to reprice its investment portfolio at higher rates and sell more spread products, and the benefits will last even as rates fall. There are understandable concerns about MetLife's CRE exposure (office in particular), as the insurer is overweight here, but losses will take years to materialize and can be absorbed. MetLife's focus on profitable core businesses like group life and health, pension risk transfer, and international markets should lead to steady growth and returns for investors. This is something of a contrarian call given weak sector sentiment, but MetLife's differentiated model and ability to out-earn its cost of equity should drive outperformance. Read the full article on Seeking AlphaSeeking Alpha • Apr 18
MetLife: Healthy But Lacks Clear Advantages
Summary MetLife has experienced a decade of light shrinking instead of growth. This started as early as 2015 and was attributed to increased competition and a decrease in annuity sales, but this never seemed to improve. With their current size, competitive hurdles, and lack of clear targets for growth internationally, shares of MET will likely only give mediocre returns at best. Read the full article on Seeking Alpha매출 및 비용 세부 내역
매출 및 비용 세부 내역
MetLife가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.
순이익 및 매출 추이
| 날짜 | 매출 | 순이익 | 일반관리비 | 연구개발비 |
|---|---|---|---|---|
| 31 Mar 26 | 77,584 | 3,434 | 0 | 0 |
| 31 Dec 25 | 77,079 | 3,173 | 0 | 0 |
| 30 Sep 25 | 71,932 | 3,634 | 0 | 0 |
| 30 Jun 25 | 73,011 | 4,091 | 0 | 0 |
| 31 Mar 25 | 73,494 | 4,305 | 0 | 0 |
| 31 Dec 24 | 70,982 | 4,226 | 0 | 0 |
| 30 Sep 24 | 71,340 | 3,561 | 0 | 0 |
| 30 Jun 24 | 68,767 | 2,708 | 0 | 0 |
| 31 Mar 24 | 67,570 | 2,166 | 0 | 0 |
| 31 Dec 23 | 66,901 | 1,380 | 0 | 0 |
| 30 Sep 23 | 63,479 | 2,355 | 0 | 0 |
| 30 Jun 23 | 69,896 | 3,031 | 0 | 0 |
| 31 Mar 23 | 68,747 | 3,542 | 0 | 0 |
| 31 Dec 22 | 68,764 | 5,099 | 0 | 0 |
| 30 Sep 22 | 73,251 | 4,726 | 0 | 0 |
| 30 Jun 22 | 67,873 | 5,149 | 0 | 0 |
| 31 Mar 22 | 70,923 | 7,634 | 0 | 0 |
| 31 Dec 21 | 68,688 | 6,654 | 0 | 0 |
| 30 Sep 21 | 70,409 | 5,301 | 0 | 0 |
| 30 Jun 21 | 69,519 | 4,413 | 0 | 0 |
| 31 Mar 21 | 65,094 | 1,115 | 0 | 0 |
| 31 Dec 20 | 67,842 | 5,191 | 0 | 0 |
| 30 Sep 20 | 65,567 | 5,603 | 0 | 0 |
| 30 Jun 20 | 68,230 | 7,122 | 0 | 0 |
| 31 Mar 20 | 71,628 | 8,738 | 0 | 0 |
| 31 Dec 19 | 69,620 | 5,721 | 0 | 0 |
| 30 Sep 19 | 68,139 | 7,195 | 0 | 0 |
| 30 Jun 19 | 65,750 | 5,923 | 0 | 0 |
| 31 Mar 19 | 69,438 | 5,084 | 0 | 0 |
| 31 Dec 18 | 67,941 | 4,982 | 0 | 0 |
| 30 Sep 18 | 68,112 | 5,244 | -252 | 0 |
| 30 Jun 18 | 67,980 | 5,235 | -166 | 0 |
| 31 Mar 18 | 62,119 | 5,197 | 0 | 0 |
| 31 Dec 17 | 62,308 | 4,893 | 0 | 0 |
| 30 Sep 17 | 59,263 | 1,893 | -33 | 0 |
| 30 Jun 17 | 58,908 | 2,044 | -28 | 0 |
| 31 Mar 17 | 57,263 | 2,229 | -97 | 0 |
| 31 Dec 16 | 60,732 | 3,481 | 0 | 0 |
| 30 Sep 16 | 65,209 | 4,994 | 368 | 0 |
| 30 Jun 16 | 67,255 | 5,169 | 355 | 0 |
| 31 Mar 16 | 69,952 | 5,219 | 342 | 0 |
| 31 Dec 15 | 61,257 | 3,891 | 0 | 0 |
| 30 Sep 15 | 71,888 | 5,857 | 333 | 0 |
| 30 Jun 15 | 72,677 | 6,724 | 350 | 0 |
양질의 수익: MET는 고품질 수익을 보유하고 있습니다.
이익 마진 증가: MET의 현재 순 이익률 (4.4%)은 지난해 (5.9%)보다 낮습니다.
잉여현금흐름 대비 순이익 분석
과거 순이익 성장 분석
수익추이: MET의 수익은 지난 5년 동안 연평균 8% 감소했습니다.
성장 가속화: MET은 지난 1년 동안 수익이 감소하여 5년 평균과 비교할 수 없습니다.
수익 대 산업: MET은 지난 1년 동안 수익이 감소(-20.2%)하여 Insurance 업계 평균(36.2%)과 비교하기 어렵습니다.
자기자본이익률
높은 ROE: MET의 자본 수익률(13%)은 낮음으로 평가됩니다.
총자산이익률
투하자본수익률
우수한 과거 실적 기업을 찾아보세요
기업 분석 및 재무 데이터 상태
| 데이터 | 최종 업데이트 (UTC 시간) |
|---|---|
| 기업 분석 | 2026/05/24 09:35 |
| 종가 | 2026/05/22 00:00 |
| 수익 | 2026/03/31 |
| 연간 수익 | 2025/12/31 |
데이터 소스
당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.
| 패키지 | 데이터 | 기간 | 미국 소스 예시 * |
|---|---|---|---|
| 기업 재무제표 | 10년 |
| |
| 분석가 컨센서스 추정치 | +3년 |
|
|
| 시장 가격 | 30년 |
| |
| 지분 구조 | 10년 |
| |
| 경영진 | 10년 |
| |
| 주요 개발 | 10년 |
|
* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.
별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.
분석 모델 및 스노우플레이크
이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.
Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.
산업 및 섹터 지표
산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.
분석가 소스
MetLife, Inc.는 32명의 분석가가 다루고 있습니다. 이 중 9명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
| 분석가 | 기관 |
|---|---|
| Jacob Kilstein | Argus Research Company |
| Jay Gelb | Barclays |
| Taylor Scott | Barclays |